Cannabis
Gaensel Energy Group, Inc., GEGR, Completes Agreement to Acquire 100% of Curatio Life Sciences, Inc.
Salt Lake City, Utah–(Newsfile Corp. – November 15, 2021) – Gaensel Energy Group, Inc., (OTC Pink: GEGR) (“Gaensel” or the “Company”), a diversified holding company with assets in Biotech, Cryptocurrency, Software/Gaming and VR, Health, Beauty and Fashion, Technology, High Tech Music and Audio Systems, CRM & Data, Commodities, Retail Coffee, as well as General Contracting and Patented Building supplies, is pleased to announce its has reached an agreement to acquire One Hundred Percent (100%) of California based Curatio Life Sciences, Inc.
Curatio Life Sciences, Inc., headquartered in Encinitas, California, https://www.curatiocbd.com, provides a new dimension in medical grade full spectrum CBD therapy. Curatio specializes in potent hemp-based medicine with the strongest combination of cannabinoids, terpenes, and triglycerides delivered in a powerful nano absorption technology. Curatio’s state-of-the-art CBD product line is recommended by a network of over 4,000 healthcare professionals, distributors, and retail stores worldwide. “We are the Doctor’s choice as a powerful natural option for a variety health conditions.” Curatio has premium line of CBD products (11 SKUs) with unique formulations, including a CBD enhanced hand sanitizers which provides protection against viruses including the Delta variant of Coronavirus, https://www.curatiocbd.com/why-cbd-makes-a-great-ingredient-in-hand-sanitizer/.
Curatio has developed a distribution network with CBD Emporium, https://cbdemporium.com/collections/curatio-cbd , with over forty (40) retail stores and with the financial assistance from Gaensel Energy continue its onboarding with Threshold Distributors and its over 11,000 retail outlets, the Threshold onboarding was postponed due to the coronavirus.
Our President, Maria Bomboi, states “We are very pleased with the acquisition of Curatio where its current United States operations will complement our Flowers CBD operations in Europe. Both the Flowers group and Curatio management combined will provide for a global CBD operation and provide an excellent investment for our shareholders.”
Additionally, on November 12, 2021, in conjunction with “New to the Street”, our CEO, Michael Clebnik, Metro VR Studios, was interview by Jane King, we anticipate airing on Nasdaq TV during the week of November 20th, 2021,
About Gaensel Energy Group, Inc. (OTC Pink: GEGR):
Gaensel Energy Group asset base currently consists of proven companies in Biotech, Commodities, Health, Beauty – Fashion, Green and Renewable Energy, and Technology. The management teams for each of these divisions are actively seeking similar partners in each space for expansion and additional acquisitions. We have been listed on the United States OTC Markets since 2002 and the Company is current. Our current private placement offering: https://ppm.gegrgroup.com/.
Gaensel Energy Group, Inc.
57 West 200 South
Suite 300
Salt Lake City, UT 84101
[email protected]
Phone: +1 518-567-3649
https://www.gegrgroup.com
https://twitter.com/gegrgroup
Forward-looking statements
This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of Gaensel Energy Group, Inc., (GEGR), and certain of the plans and objectives of GEGR with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. Forward-looking statements can be identified generally as those containing words such as “anticipates”, “assumes”, “believes”, “estimates”, “expects”, “should”, “will”, “will likely result”, “forecast”, “outlook”, “projects”, “may” or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
These factors include, but are not limited to, domestic and global economic and business conditions, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where GEGR operates, industry consolidation and competition. As a result, GEGR actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/103530
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis3 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt3 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace